🇨🇳

China

Asia Pacific

China's biotech sector has exploded over the past decade with massive government investment and a growing talent pool of returnees from US/EU pharma. Shanghai's Zhangjiang Hi-Tech Park is China's biotech capital.

Biotech Market Cap

$297.7B

Public Companies

Total Companies

560

30D Performance

-26.86%

BIOTECH MARKET CAP INDEX

$297.7B+173504.0%ALL

BIOTECH HUBS

ShanghaiBeijingSuzhouShenzhenGuangzhou

COMPANIES

#	Company	Valuation
1	Jiangsu Hengrui Medicine600276.SS	$51.5B
2	Hansoh Pharma3692.HK	$28.1B
3	Innovent Biologics1801.HK	$19.9B
4	WuXi BiologicsWXXWY	$17.9B
5	Sichuan Biokin Pharmaceutical688506.SS	$16.1B
6	Akeso9926.HK	$15.8B
7	CSPC Pharmaceutical Group Limited1093.HK	$11.9B
8	Fosun Pharma600196.SS	$9.7B
9	WuXi Apptec2359.HK	$9.1B
10	Haisco Pharmaceutical Group002653.SZ	$9.0B
11	Huadong Medicine (HD Medicine)000963.SZ	$8.6B
12	Shenzhen Salubris Pharmaceuticals002294.SZ	$7.9B
13	Pharmaron Beijing300759.SZ	$7.4B
14	CSPC Innovation Pharmaceutical300765.SZ	$6.6B
15	Shanghai Allist Pharmaceuticals688578.SS	$6.3B
16	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.300255.SZ	$6.2B
17	Tong Ren Tang600085.SS	$5.6B
18	Shanghai RAAS Blood Products002252.SZ	$5.5B
19	Zhifei Biological Products300122.SZ	$5.4B
20	Guangzhou Baiyunshan Pharmaceutical Holdings600332.SS	$5.4B